August 22, 2017 7:50 AM ET

Pharmaceuticals

Company Overview of Spear Therapeutics Ltd.

Company Overview

Spear Therapeutics Ltd. develops prodrugs for the treatment of cancer. It offers cytochrome P450 (CYP)-activated prodrugs, which include aromatic hydroxylation activators, nitric/nitrogen oxide release agents, and compounds possessing specific CYP enzyme-activated drug release activity. The company was incorporated in 2002 and is based in London, United Kingdom. As of January 28, 2015, Spear Therapeutics Ltd. operates as a subsidiary of Incanthera Ltd.

Sardinia House

6th Floor

London,  WC2 A3PF

United Kingdom

Founded in 2002

Key Executives for Spear Therapeutics Ltd.

Co-Founder
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
Abbey Pharma Limited Europe
Absynth Biologics Limited Europe
Acacia Pharma Limited Europe
AccentBio Ltd. Europe
Aclar Limited Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States
Bertelsmann AG Europe
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Spear Therapeutics Ltd., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.